Our Services
Others
- DFPP
- Shockwave
- IV Drip

Vega Medical Services, a prominent leader in regenerative medicine and stem cell therapy, is delighted to announce significant outcomes from a recent investigation into the therapeutic potential of utilised human mesenchymal stem cell (MSC) culture media. The study revealed that the conditioned medium—obtained following the cultivation of human umbilical cord-derived MSCs—demonstrates exceptional wound-healing capabilities, indicating a valuable new application for this frequently overlooked byproduct of stem cell culture.
The research incorporated StemGold, a high-quality MSC culture medium developed by AGEM Bio, a biotechnology company originating from the National University of Singapore (NUS). Specifically formulated to enhance cellular vitality and promote the secretion of bioactive compounds, StemGold was instrumental in generating a potent conditioned medium abundant in regenerative factors.
Using a standardized scratch assay—an established in vitro wound healing model—Vega Medical Services evaluated the wound closure efficiency of used UC-MSC culture media in comparison to both untreated controls and Aloe Vera-treated samples, the latter serving as a positive control.
The findings were remarkable:
This accelerated wound closure and enhanced cellular migration underscore the high bioactivity of the secretome secreted by mesenchymal stem cells during expansion. These results position used culture media as a promising, scalable, and cost-effective resource for future applications in regenerative medicine and advanced therapeutic strategies.
At the heart of these promising results lies the stem cell secretome—a complex mixture of biologically active molecules naturally released by mesenchymal stem cells (MSCs) into their culture environment. This rich blend plays a pivotal role in driving tissue repair and regeneration, and includes:
Growth Factors: Such as VEGF, EGF, TGF-β, and FGF, which are essential for promoting angiogenesis, stimulating tissue regeneration, and supporting cellular proliferation and differentiation.
Cytokines and Chemokines: These signalling molecules help regulate inflammation and recruit immune and progenitor cells to sites of injury, facilitating coordinated repair processes.
Peptides and Structural Proteins: Contribute to collagen synthesis and extracellular matrix remodeling, both vital for restoring tissue strength and integrity.
Exosomes and Extracellular Vesicles: These nanoscale vesicles carry genetic material, proteins, and lipids between cells, orchestrating complex healing pathways and enhancing cell-to-cell communication.
Together, these components of the MSC secretome represent a powerful, cell-free therapeutic strategy, offering new possibilities for regenerative treatments without the complexities of direct stem cell transplantation.
The implications of this discovery are far-reaching, as the healing factors found in used stem cell culture media offer transformative potential across multiple fields. This cell-free, biologically active solution may be harnessed in a wide range of clinical and commercial applications, including:
By unlocking the therapeutic potential of the MSC secretome, Vega Medical Services is opening the door to a new generation of regenerative treatments that are safe, scalable, and highly effective.
StemGold, developed by AGEM Bio, is a serum-free, xeno-free medium engineered to maximize stem cell viability, proliferation, and secretory output. Its optimized formulation enhances the secretion of bioactive factors, making it ideal for harvesting a robust therapeutic secretome.
One of the greatest benefits of using conditioned stem cell media is that it is cell-free, eliminating the challenges associated with live cell therapies such as storage, immune rejection, and regulatory barriers. Instead, it offers:
– Ease of use in topical or injectable formulations
– Stability and shelf life for commercial products
– Safety due to absence of live cells or immunogenic material
– Cost-effectiveness for scalable healthcare and beauty applications
With this breakthrough, Vega Medical Services is pioneering a new era in regenerative medicine—where every output of stem cell culture, including conditioned media, is seen as a therapeutic asset. Used culture media is no longer waste; it is a bioactive reservoir with immense potential for wound care, dermatology, and anti-aging therapies.
Vega Medical Services is a Thailand-based leader in regenerative medicine, stem cell technologies, and cell-derived therapies. Through cutting-edge research and global partnerships, Vega delivers clinically validated solutions in stem cell science to support human health, longevity, and beauty.
Vega Medical Services
3/6, The Primary 101, Soi Lad Phrao 101
Lad Phrao Road, Khlong Chan
Bang Kapi District, Bangkok 10240
Thailand
Email: vegastemcell@gmail.com
Tel & WhatsApp: +66 (0) 86 691 6915
Website: www.vegastemcell.com